BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26667950)

  • 1. [The IMPROVE-IT trial showed no favorable effects on well-defined and clinically relevant endpoints].
    Mascitelli L; Goldstein MR
    G Ital Cardiol (Rome); 2015 Dec; 16(12):739. PubMed ID: 26667950
    [No Abstract]   [Full Text] [Related]  

  • 2. [The IMPROVE-IT trial].
    Menozzi A; Lina D; Urbinati S; Greco C
    G Ital Cardiol (Rome); 2015 Dec; 16(12):667-71. PubMed ID: 26667942
    [No Abstract]   [Full Text] [Related]  

  • 3. [Letter].
    Poli A
    G Ital Cardiol (Rome); 2015 Dec; 16(12):739-40. PubMed ID: 26667952
    [No Abstract]   [Full Text] [Related]  

  • 4. Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria.
    Virani SS; Akeroyd JM; Nambi V; Maddox TM; Gillette MA; Michael Ho P; Rumsfeld J; Petersen LA; Ballantyne CM
    Am J Med; 2015 Nov; 128(11):1253-6. PubMed ID: 26071828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Clinicians Improve on the Effectiveness of Statins with Additional Lipid-lowering Therapies?
    Frishman WH
    Am J Med; 2015 Nov; 128(11):1160-1. PubMed ID: 26184685
    [No Abstract]   [Full Text] [Related]  

  • 6. Ezetimibe: Clinical and Scientific Meaning of the IMPROVE-IT Study.
    Correia LC
    Arq Bras Cardiol; 2016 Mar; 106(3):247-9. PubMed ID: 27027368
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
    Bohula EA; Wiviott SD; Giugliano RP; Blazing MA; Park JG; Murphy SA; White JA; Mach F; Van de Werf F; Dalby AJ; White HD; Tershakovec AM; Cannon CP; Braunwald E
    Circulation; 2017 Dec; 136(25):2440-2450. PubMed ID: 28972004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
    Lancellotti P; Pierard LA; Scheen AJ
    Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe + statin: insufficient benefit.
    Prescrire Int; 2016 Oct; 25(175):245-246. PubMed ID: 30645833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Singh JS; Struthers AD; Lang CC
    N Engl J Med; 2015 Oct; 373(15):1476. PubMed ID: 26444741
    [No Abstract]   [Full Text] [Related]  

  • 11. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Richard T; Lelubre C; Vanhaeverbeek M
    N Engl J Med; 2015 Oct; 373(15):1475-6. PubMed ID: 26444740
    [No Abstract]   [Full Text] [Related]  

  • 12. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Nunes JP
    N Engl J Med; 2015 Oct; 373(15):1475. PubMed ID: 26444739
    [No Abstract]   [Full Text] [Related]  

  • 13. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Patti G; Cavallari I
    N Engl J Med; 2015 Oct; 373(15):1474-5. PubMed ID: 26444738
    [No Abstract]   [Full Text] [Related]  

  • 14. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Egom EE
    N Engl J Med; 2015 Oct; 373(15):1474. PubMed ID: 26444737
    [No Abstract]   [Full Text] [Related]  

  • 15. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Couture P; Durand M; Laskine M
    N Engl J Med; 2015 Oct; 373(15):1473-4. PubMed ID: 26444736
    [No Abstract]   [Full Text] [Related]  

  • 16. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Silbernagel G; Baumgartner I; März W
    N Engl J Med; 2015 Oct; 373(15):1473. PubMed ID: 26444735
    [No Abstract]   [Full Text] [Related]  

  • 17. Ezetimibe plus a Statin after Acute Coronary Syndromes.
    Cannon CP; Blazing MA; Braunwald E
    N Engl J Med; 2015 Oct; 373(15):1476-7. PubMed ID: 26444734
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of ezetimibe in secondary cardiovascular prevention finally determined?].
    Lanzi D; Fumeaux T
    Rev Med Suisse; 2015 Nov; 11(496):2257. PubMed ID: 26742360
    [No Abstract]   [Full Text] [Related]  

  • 19. Ezetimibe-Statin Combination to Reduce Cardiovascular Events: The Evidence Base.
    Jialal I; Abate N
    Metab Syndr Relat Disord; 2015 Oct; 13(8):327-8. PubMed ID: 26177147
    [No Abstract]   [Full Text] [Related]  

  • 20. Ezetimibe provides incremental reduction in risk for cardiovascular events and need for revascularisation following an acute coronary syndrome.
    Toth PP
    Evid Based Med; 2015 Oct; 20(5):176. PubMed ID: 26261287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.